Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05950607 · ClinicalTrials.gov registry record · NA

Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0

A NA study of Alzheimer Disease and Dementia, sponsored by Hebrew SeniorLife.

Recruiting
Registry status
NA
Development phase
750
Enrollment target
1
Study location

NCT05950607 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by Hebrew SeniorLife. The registered enrollment target is 750 participants, below the 2,748-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05950607, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by Hebrew SeniorLife.

RECRUITING
Registry status
NA
Development phase
750 participants
Enrollment target
1
Study location

Study Summary

The goal of this pragmatic cluster randomized clinical trial is to compare management of suspected infection in nursing home residents with dementia The main questions it aims to answer whether residents with dementia in nursing homes randomized to use a multicomponent intervention to optimize suspected infection management ( versus usual care) use less antibiotics and fewer burdensome interventions.

Conditions Studied

Alzheimer Disease Dementia Infections

Interventions

  • BEHAVIORAL TRAIN AD 2.0

Study Locations (1)

Massachusetts

  • Hebrew SeniorLife - Boston

Trial Details

FieldValue
Enrollment Target 750 participants
Start Date 2023-11-13
Est. Completion 2026-06-30
Phase NA

Sponsor

Hebrew SeniorLife

32 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05950607

The ClinicalTrials.gov registry entry for NCT05950607 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (73% lower). The listed sponsor is Hebrew SeniorLife, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which TRAIN AD 2.0 is the first listed.

NCT05950607 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05950607 about?

NCT05950607 is a clinical study titled "Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0". The goal of this pragmatic cluster randomized clinical trial is to compare management of suspected infection in nursing home residents with dementia The main questions it aims to answer whether residents with dementia in nursing homes randomized to use a multicomponent intervention to optimize suspe...

What is the current status of trial NCT05950607?

This trial is currently recruiting. It is a NA study. The enrollment target is 750 participants. The study started on 2023-11-13. Estimated completion is 2026-06-30.

What conditions does trial NCT05950607 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Infections.

What interventions are being tested in trial NCT05950607?

The interventions under investigation include: TRAIN AD 2.0 (BEHAVIORAL).

Who is sponsoring clinical trial NCT05950607?

This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05950607 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Dementia

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.